Magnetic Resonance-Based Texture Analysis Differentiating KRAS Mutation Status in Rectal Cancer
- Author:
Ji Eun OH
1
;
Min Ju KIM
;
Joohyung LEE
;
Bo Yun HUR
;
Bun KIM
;
Dae Yong KIM
;
Ji Yeon BAEK
;
Hee Jin CHANG
;
Sung Chan PARK
;
Jae Hwan OH
;
Sun Ah CHO
;
Dae Kyung SOHN
Author Information
- Publication Type:Original Article
- From:Cancer Research and Treatment 2020;52(1):51-59
- CountryRepublic of Korea
- Language:0
-
Abstract:
Purpose:Mutation of the Kirsten Ras (KRAS) oncogene is present in 30%-40% of colorectal cancers and has prognostic significance in rectal cancer. In this study, we examined the ability of radiomics features extracted from T2-weighted magnetic resonance (MR) images to differentiate between tumors with mutant KRAS and wild-type KRAS.
Materials and Methods:Sixty patients with primary rectal cancer (25 with mutant KRAS, 35 with wild-type KRAS) were retrospectively enrolled. Texture analysis was performed in all regions of interest on MR images, which were manually segmented by two independent radiologists. We identified potentially useful imaging features using the two-tailed t test and used them to build a discriminant model with a decision tree to estimate whether KRAS mutation had occurred.
Results:Three radiomic features were significantly associated with KRASmutational status (p < 0.05). The mean (and standard deviation) skewness with gradient filter value was significantly higher in the mutant KRAS group than in the wild-type group (2.04±0.94 vs. 1.59±0.69). Higher standard deviations for medium texture (SSF3 and SSF4) were able to differentiate mutant KRAS (139.81±44.19 and 267.12±89.75, respectively) and wild-type KRAS (114.55±29.30 and 224.78±62.20). The final decision tree comprised three decision nodes and four terminal nodes, two of which designated KRAS mutation. The sensitivity, specificity, and accuracy of the decision tree was 84%, 80%, and 81.7%, respectively.
Conclusion:Using MR-based texture analysis, we identified three imaging features that could differentiate mutant from wild-type KRAS. T2-weighted images could be used to predict KRAS mutation status preoperatively in patients with rectal cancer.
